IP Library Granted Patent US 11,079,719
Granted Patent B2
US 11,079,719 · App. 16/028,287 · Granted Aug 3, 2021

Lens-free holographic optical system for high sensitivity label-free microbial growth detection and quantification for screening, identification, and susceptibility testing

Inventor: Oleg Gusyatin (Tucson, AZ)
Assignee: Accelerate Diagnostics, Inc.
G03H1/10C12M41/36G01N15/0227G01N15/1434G01N15/1475G01N23/20G02B21/0008G02B21/365G03H1/0443G01N2015/0233G01N2015/1006G01N2015/1454G01N2015/1493G01N2015/1497G03H1/0866G03H2001/0033G03H2001/0447G03H2001/2655G03H2222/13G03H2222/52G03H2226/13G03H2227/03
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,079,719
App. No.
16/028,287
Granted
Aug 3, 2021
Kind
B2
Abstract

Disclosed are optical interrogation apparatus that can produce lens-free images using an optoelectronic sensor array to generate a holographic image of sample objects, such as microorganisms in a sample. Also disclosed are methods of detecting and/or identifying microorganisms in a biological sample, such as microorganisms present in low levels. Also disclosed are methods of using systems to detect microorganisms in a biological sample, such as microorganisms present in low levels. In addition or as an alternative, the methods of using systems may identify microorganisms present in a sample and/or determine antimicrobial susceptibility of such microorganisms.

Claims (31)

1. An automated system, comprising:

an automated holographic optical apparatus situated to determine at least antimicrobial susceptibility of a microorganism corresponding to an object in a sample volume based on a detected variation over time of a hologram of the sample volume, an output of at least one deeply supervised convolutional neural network, and a phenotypical behavior of the microorganism, wherein the phenotypical behavior of the microorganism is classified based on the detected variation and the output of the at least one deeply supervised convolutional neural network,

wherein the holographic optical apparatus is an in-line holographic apparatus and the hologram is an in-line hologram; and

wherein the in-line holographic optical apparatus includes a reference beam source situated to direct a reference beam to the sample volume, a sample receptacle situated to hold the sample volume in view of the reference beam, an optical sensor situated to detect the in-line hologram formed by the reference beam and the sample volume, and a controller coupled to the optical sensor and that includes at least one processor and one or more computer-readable storage media including stored instructions that, responsive to execution by the at least one processor, cause the controller to determine the variation over time of the in-line hologram.

2. The system of claim 1 , wherein the controller is configured to reconstruct the spatial characteristics of the sample volume based on the detected in-line hologram, diffraction propagation approximation, and a phase retrieval algorithm.

3. The system of claim 2 , wherein the controller is configured to determine a focal plane of the microorganism in the sample volume based on the reconstructed spatial characteristics.

4. The system of claim 1 , wherein the at least one deeply supervised convolutional neural network includes a spatial reconstruction deeply supervised convolutional neural network configured to produce an output corresponding to a reconstruction of the spatial characteristics of the sample volume based on a trained set of network layers, and wherein the controller is configured to reconstruct the spatial characteristics of the sample volume using the reconstruction deeply supervised convolutional neural network.

5. The system of claim 1 , wherein the at least one deeply supervised convolutional neural network includes a microorganism identification deeply supervised convolutional neural network configured to produce an output corresponding to a microorganism identification, microorganism morphology identification, microorganism movement identification, and/or microorganism phenotypic classification for the microorganism in the sample volume based on a trained set of network layers, and wherein the controller is configured to identify the microorganism, microorganism morphology, microorganism movement, and/or classify the microorganism phenotypical behavior using the microorganism identification deeply supervised convolutional neural network.

6. The system of claim 1 , wherein the controller is configured to determine a 3D position and/or morphological characteristics of the microorganism based on the in-line hologram.

7. The system of claim 1 , wherein the controller is configured to associate the object detected in a later hologram with the object detected in an earlier hologram, based on proximity or morphological characteristics of the objects detected from the variation over time of the in-line hologram.

8. The system of claim 1 , wherein the controller is configured to form an object track for the object in the sample volume based on the detected variation over time of the in-line hologram.

9. The system of claim 1 , wherein the controller is configured to identify the object as the microorganism in the sample volume based on the detected variation over time of the in-line hologram.

10. The system of claim 1 , wherein the controller is configured to classify a phenotypical behavior of the microorganism in the sample volume based on the detected in-line hologram.

11. The system of claim 10 , wherein the controller is configured to determine a correspondence between the phenotypic behavior of the microorganism and presence, concentration, and taxon of the microorganism in the sample volume.

12. The system of claim 11 , wherein the sample volume includes a plurality of sample volume portions situated in a respective at least one growth control, at least one selective media, and at least one antimicrobial flow cell that are held by the sample receptacle, and the controller is configured to determine the presence, taxon, and an antibiogram of the microorganism or multiple microorganisms based on the at least one growth control, the at least one selective media, and the at least one antimicrobial flow cell.

13. The system of claim 1 , wherein the optical sensor is a complementary metal oxide semiconductor (CMOS) sensor having a pixel pitch of 1.5 μm or smaller.

14. The system of claim 1 , wherein the optical sensor has a pixel pitch of 1 μm/pixel or smaller and the controller is configured to determine, based on the detected in-line hologram, morphological characteristics of the microorganism.

15. The system of claim 1 , wherein the reference beam source includes a plurality of pinhole apertures spaced apart from each other by 1 mm or less with each of the pinhole apertures configured to emit respective reference subbeams at different respective wavelengths.

16. The system of claim 1 , wherein the reference beam source includes a pinhole aperture situated to receive illumination from an illumination source and the reference beam source is configured to direct the reference beam lens-free from the pinhole aperture to the sample volume and optical sensor.

17. The system of claim 16 , wherein the illumination source is configured to generate illumination at multiple wavelengths.

18. The system of claim 16 , wherein the illumination received from the illumination source by the pinhole aperture is incoherent and the reference beam comprises incoherent illumination.

19. The system of claim 1 , wherein the reference beam source is situated to direct a plurality of reference beams to the sample volume and to adjacent portions of the optical sensor so as to mosaic the field of view of the in-line holographic apparatus.

20. The system of claim 19 , wherein the adjacent portions of the optical sensor correspond to separate CMOS sensors.

21. The system of claim 19 , wherein the sample volume includes a plurality of sample volume portions, including a first sample volume portion situated in a first sample reaction chamber that is held by the sample receptacle, wherein the first sample volume portion is situated as a growth control volume by having an absence of an antimicrobial agent, and including a second sample volume portion situated in a second sample reaction chamber, wherein the second volume portion is situated as an antimicrobial susceptibility test volume in the presence of a predetermined antimicrobial agent.

22. The system of claim 21 , wherein the sample reaction chambers include a plurality of growth channels having selective media.

23. The system of claim 1 , wherein the holographic apparatus is situated to determine a presence of the microorganism based on the detected variation with the sample volume having a microorganism concentration of 10 cfu/mL or less.

24. The system of claim 1 , wherein the holographic apparatus is situated to display a time-lapse image associated with the sample volume at a time-resolution that is faster than a microorganism division rate.

25. The system of claim 24 , wherein the time-lapse image corresponds to one or more of the hologram and one or more planes of the sample volume.

26. The system of claim 1 , wherein a time period of the detected variation corresponds to four or fewer microorganism doubling events.

27. The system of claim 1 , wherein a time period of the detected variation corresponds to three or fewer microorganism doubling events.

28. The system of claim 1 , wherein the microorganism is immobilized in the sample volume.

Assignments (6)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 30, 2026
From: AST REVOLUTION, LLC
To: ELITECHGROUP INC.
Reel/Frame 074217/0890 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 19, 2025
From: ACCELERATE DIAGNOSTICS, INC.; ACCELERATE DIAGNOSTICS TEXAS, LLC.
To: AST REVOLUTION, LLC
Reel/Frame 072314/0691 →
SECURITY INTEREST Recorded Aug 8, 2024
From: ACCELERATE DIAGNOSTICS, INC.
To: U.S. BANK TRUST COMPANY, NATIONAL ASSOCIATION
Reel/Frame 068222/0638 →
SECURITY INTEREST Recorded May 16, 2024
From: ACCELERATE DIAGNOSTICS, INC.
To: U.S. BANK TRUST COMPANY, NATIONAL ASSOCIATION
Reel/Frame 067430/0886 →
SECURITY INTEREST Recorded Jun 9, 2023
From: ACCELERATE DIAGNOSTICS, INC.
To: U.S. BANK TRUST COMPANY, NATIONAL ASSOCIATION
Reel/Frame 063912/0050 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 6, 2018
From: GUSYATIN, OLEG
To: ACCELERATE DIAGNOSTICS, INC.
Reel/Frame 046279/0166 →
Continuity (2)
Provisional Application 62528825 · Jul 5, 2017
Related Publication 20190011882A1 · Jan 10, 2019